Sign In
Buy HRMY
$35.54
-1.30 (-3.53%)
At Close: Jul 13, 2026
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?
02:46pm, Monday, 29'th Jun 2026
Harmony Biosciences trades at discounted valuations, but investors are weighing Wakix dependence, recent earnings misses and pipeline execution.
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline
02:41pm, Monday, 29'th Jun 2026
Harmony Biosciences is leveraging Wakix growth to expand its neuroscience pipeline, while advancing pitolisant programs and rare disease assets.
HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase
02:41pm, Monday, 29'th Jun 2026
Harmony Biosciences is broadening beyond Wakix with pitolisant programs, orexin research and rare epilepsy assets to diversify growth.
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting
09:00am, Thursday, 11'th Jun 2026
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that six abstracts in narcolepsy and idiopathic hypersomnia have been accepted for poster pr
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting
08:05am, Thursday, 11'th Jun 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that six abstracts in narcolepsy and idiopathic hypersomnia have been accepted for poster pre
Harmony Biosciences Holdings, Inc. (HRMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
11:52am, Tuesday, 09'th Jun 2026
Harmony Biosciences Holdings, Inc. (HRMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Harmony Biosciences to Participate in Upcoming Investor Conferences
09:00am, Wednesday, 27'th May 2026
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferenc
Harmony Biosciences to Participate in Upcoming Investor Conferences
08:05am, Wednesday, 27'th May 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conference
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2026 Earnings Call Transcript
06:11pm, Thursday, 07'th May 2026
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2026 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates
09:56am, Thursday, 07'th May 2026
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.55 per share, missing the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.78 per share a y
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today reported Q1 2026 revenue of $215.4 million, delivering 17% year‑over‑year growth for WAKIX®. Perfor
Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice
01:45pm, Monday, 04'th May 2026
Harmony Biosciences (HRMY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
HRMY or ARGX: Which Is the Better Value Stock Right Now?
12:40pm, Monday, 04'th May 2026
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or argenex SE (ARGX). But which of these two stocks
Wall Street Analysts Think Harmony Biosciences (HRMY) Could Surge 34.81%: Read This Before Placing a Bet
10:56am, Monday, 04'th May 2026
The mean of analysts' price targets for Harmony Biosciences (HRMY) points to a 34.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement am
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
08:05am, Thursday, 23'rd Apr 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report first quarter 2026 financial results on Thursday, May 7, 2026, before the
